Jorge Matias-Guiu (Jorge Matías-Guiu, J Matías-Guiu)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Venues

BMJ open

Journal of clinical medicine

CNS neuroscience & therapeutics

Biomolecules

Universidad Complutense de Madrid

Universitat Autònoma de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Complutense de Madrid Jul 31 2005

Spain

Catedrático (Full professor) :: Medicine. Neurology

Education History

Universitat Autònoma de Barcelona

Spain

PHD :: Medicine. Neurology

Publications

Jordi A Matias-Guiu, Javier González-Rosa, Miguel Ángel Hernández, Maria Luisa Martínez-Ginés, Antonio Portolés, Natalia Pérez-Macías, Julián Benito-León, Iván Padrón, Julio Prieto, Jorge Matias-Guiu
Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial. BMJ open 14 (1) (2024)
María Valles-Salgado, Jordi A Matias-Guiu, Alfonso Delgado-Álvarez, Cristina Delgado-Alonso, María José Gil-Moreno, Esther Valiente-Gordillo, Juan Ignacio López-Carbonero, Lucía Fernández-Romero, Lidia Peña-DeDiego, Silvia Oliver-Mas, Jorge Matias-Guiu, Maria Diez-Cirarda
Comparison of the Diagnostic Accuracy of Five Cognitive Screening Tests for Diagnosing Mild Cognitive Impairment in Patients Consulting for Memory Loss. Journal of clinical medicine 13 (16) (2024)
Jordi A Matias-Guiu, Javier González-Rosa, Miguel Ángel Hernández, Maria Luisa Martínez-Ginés, Antonio Portolés, Natalia Pérez-Macías, Julián Benito-León, Iván Padrón, Julio Prieto, Jorge Matias-Guiu
Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial. BMJ open 14 (1) (2024)
Jordi A Matias-Guiu, Javier González-Rosa, Miguel Ángel Hernández, Maria Luisa Martínez-Ginés, Antonio Portolés, Natalia Pérez-Macías, Julián Benito-León, Iván Padrón, Julio Prieto, Jorge Matias-Guiu
Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial. BMJ open 14 (1) (2024)
Jordi A Matias-Guiu, Javier González-Rosa, Miguel Ángel Hernández, Maria Luisa Martínez-Ginés, Antonio Portolés, Natalia Pérez-Macías, Julián Benito-León, Iván Padrón, Julio Prieto, Jorge Matias-Guiu
Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial. BMJ open 14 (1) (2024)
Jordi A Matias-Guiu, Javier González-Rosa, Miguel Ángel Hernández, Maria Luisa Martínez-Ginés, Antonio Portolés, Natalia Pérez-Macías, Julián Benito-León, Iván Padrón, Julio Prieto, Jorge Matias-Guiu
Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial. BMJ open 14 (1) (2024)
María Valles-Salgado, Jordi A Matias-Guiu, Alfonso Delgado-Álvarez, Cristina Delgado-Alonso, María José Gil-Moreno, Esther Valiente-Gordillo, Juan Ignacio López-Carbonero, Lucía Fernández-Romero, Lidia Peña-DeDiego, Silvia Oliver-Mas, Jorge Matias-Guiu, Maria Diez-Cirarda
Comparison of the Diagnostic Accuracy of Five Cognitive Screening Tests for Diagnosing Mild Cognitive Impairment in Patients Consulting for Memory Loss. Journal of clinical medicine 13 (16) (2024)
Lilia Carolina León-Moreno, Edwin Estefan Reza-Zaldívar, Mercedes Azucena Hernández-Sapiéns, Erika Villafaña-Estarrón, Marina García-Martin, Doddy Denise Ojeda-Hernández, Jordi A Matias-Guiu, Ulises Gómez-Pinedo, Jorge Matias-Guiu, Alejandro Arturo Canales-Aguirre
Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities. Biomolecules 14 (1) (2023)
Lilia Carolina León-Moreno, Edwin Estefan Reza-Zaldívar, Mercedes Azucena Hernández-Sapiéns, Erika Villafaña-Estarrón, Marina García-Martin, Doddy Denise Ojeda-Hernández, Jordi A Matias-Guiu, Ulises Gómez-Pinedo, Jorge Matias-Guiu, Alejandro Arturo Canales-Aguirre
Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities. Biomolecules 14 (1) (2023)
Ulises Gómez-Pinedo, Jordi A Matias-Guiu, Doddy Denise Ojeda-Hernández, Sarah de la Fuente-Martin, Ola Mohamed-Fathy Kamal, Maria Soledad Benito-Martin, Belen Selma-Calvo, Paloma Montero-Escribano, Jorge Matias-Guiu
In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies. Cells 12 (11) (2023)
Lilia Carolina León-Moreno, Edwin Estefan Reza-Zaldívar, Mercedes Azucena Hernández-Sapiéns, Erika Villafaña-Estarrón, Marina García-Martin, Doddy Denise Ojeda-Hernández, Jordi A Matias-Guiu, Ulises Gómez-Pinedo, Jorge Matias-Guiu, Alejandro Arturo Canales-Aguirre
Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities. Biomolecules 14 (1) (2023)
Laura Hernández-Lorenzo, Maria José Gil-Moreno, Isabel Ortega-Madueño, Maria Cruz Cárdenas, Maria Diez-Cirarda, Alfonso Delgado-Álvarez, Marta Palacios-Sarmiento, Jorge Matias-Guiu, Silvia Corrochano, José L Ayala, Jordi A Matias-Guiu, null null
A data-driven approach to complement the A/T/(N) classification system using CSF biomarkers. CNS neuroscience & therapeutics (2023)
Cristina Delgado-Alonso, María Valles-Salgado, Alfonso Delgado-Álvarez, Maria Natividad Gómez Ruiz, Miguel Yus, Carmen Polidura, Carlos Pérez-Izquierdo, Alberto Marcos, María José Gil, Jorge Matias-Guiu, Jordi A Matias-Guiu
Examining Association of Personality Characteristics and Neuropsychiatric Symptoms in Post-COVID Syndrome. Brain sciences 12 (2) (2022)
Eneritz López-Muguruza, Natalia Villar-Gómez, Jordi A Matias-Guiu, Belen Selma-Calvo, Lidia Moreno-Jimenez, Francisco Sancho-Bielsa, Juan Lopez-Carbonero, María Soledad Benito-Martín, Silvia García-Flores, Natalia Bonel-García, Ola Mohamed-Fathy Kamal, Doddy Denise Ojeda-Hernández, Jorge Matias-Guiu, Ulises Gómez-Pinedo
The Integration of Cell Therapy and Biomaterials as Treatment Strategies for Remyelination. Life (Basel, Switzerland) 12 (4) (2022)
Doddy Denise Ojeda-Hernández, Alejandro Arturo Canales-Aguirre, Jordi A Matias-Guiu, Jorge Matias-Guiu, Ulises Gómez-Pinedo, Juan Carlos Mateos-Díaz
Chitosan-Hydroxycinnamic Acids Conjugates: Emerging Biomaterials with Rising Applications in Biomedicine. International journal of molecular sciences 23 (20) (2022)
Cristina Delgado-Alonso, Constanza Cuevas, Silvia Oliver-Mas, Maria Diez-Cirarda, Alfonso Delgado-Álvarez, María José Gil-Moreno, Jorge Matias-Guiu, Jordi A Matias-Guiu
Fatigue and Cognitive Dysfunction Are Associated with Occupational Status in Post-COVID Syndrome. International journal of environmental research and public health 19 (20) (2022)
Doddy Denise Ojeda-Hernández, Mercedes Azucena Hernández-Sapiéns, Edwin E Reza-Zaldívar, Alejandro Arturo Canales-Aguirre, Jordi A Matias-Guiu, Jorge Matias-Guiu, Juan Carlos Mateos-Díaz, Ulises Gómez-Pinedo, Francisco Sancho-Bielsa
Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis. Life (Basel, Switzerland) 12 (9) (2022)
Jordi A Matias-Guiu, Cristina Delgado-Alonso, Maria Diez-Cirarda, Álvaro Martínez-Petit, Silvia Oliver-Mas, Alfonso Delgado-Álvarez, Constanza Cuevas, María Valles-Salgado, María José Gil, Miguel Yus, Maria Natividad Gómez Ruiz, Carmen Polidura, Josué Pagán, Jorge Matias-Guiu, José Luis Ayala
Neuropsychological Predictors of Fatigue in Post-COVID Syndrome. Journal of clinical medicine 11 (13) (2022)
Natalia Villar-Gómez, Doddy Denise Ojeda-Hernández, Eneritz López-Muguruza, Silvia García-Flores, Natalia Bonel-García, María Soledad Benito-Martín, Belen Selma-Calvo, Alejandro Arturo Canales-Aguirre, Juan Carlos Mateos-Díaz, Paloma Montero-Escribano, Jordi A Matias-Guiu, Jorge Matias-Guiu, Ulises Gómez-Pinedo
Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders. Cells 11 (19) (2022)
Ulises Gómez-Pinedo, Jordi A Matías-Guiu, María Soledad Benito-Martín, Lidia Moreno-Jimenez, Inmaculada Sanclemente-Alamán, Belen Selma-Calvo, Sara Pérez-Suarez, Francisco Sancho-Bielsa, Alejandro Canales-Aguirre, Juan Carlos Mateos-Díaz, Mercedes Azucena Hernández-Sapiéns, Edwin E Reza-Zaldívar, Doddy Denise Ojeda-Hernández, Lucía Vidorreta-Ballesteros, Paloma Montero-Escribano, Jorge Matias-Guiu
Intranasal Administration of Undifferentiated Oligodendrocyte Lineage Cells as a Potential Approach to Deliver Oligodendrocyte Precursor Cells into Brain. International journal of molecular sciences 22 (19) (2021)
Jose Medina-Polo, José María Adot, Marta Allué, Salvador Arlandis, Pedro Blasco Hernández, Bonaventura Casanova, Jorge Matias-Guiu, Blanca Madurga, Edwin-Roger Meza-Murillo, Carlos Müller-Arteaga, Breogán Rodríguez-Acevedo, Jesús Vara, María Carmen Zubiaur, Luis López-Fando
Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis. Neurourology and urodynamics 39 (2) (2020)
Ulises Gómez-Pinedo, Jorge Matias-Guiu, Inmaculada Sanclemente-Alaman, Lidia Moreno-Jimenez, Paloma Montero-Escribano, Jordi A Matias-Guiu
SARS-CoV-2 as a Potential Trigger of Neurodegenerative Diseases. Movement disorders : official journal of the Movement Disorder Society 35 (7) (2020)
Laura Torre-Fuentes, Jordi A Matias-Guiu, Vanesa Pytel, Paloma Montero-Escribano, Paolo Maietta, Sara Álvarez, Ulises Gómez-Pinedo, Jorge Matias-Guiu
Variants of genes encoding TNF receptors and ligands and proteins regulating TNF activation in familial multiple sclerosis. CNS neuroscience & therapeutics 26 (11) (2020)
Jesús Porta Etessam, Nuria Gonzalez-Garcia, Jordi A Matias-Guiu, Paloma Montero-Escribano, Jorge Matias-Guiu
Should We Adapt the Prescription Criteria for Specific Treatments for Migraine Due to the COVID-19 Pandemic? Headache 60 (7) (2020)
Ulises Gómez-Pinedo, Jorge Matias-Guiu, Inmaculada Sanclemente-Alaman, Lidia Moreno-Jimenez, Paloma Montero-Escribano, Jordi A Matias-Guiu
Is the brain a reservoir organ for SARS-CoV2? Journal of medical virology 92 (11) (2020)
Jorge Matias-Guiu, Laura Torre-Fuentes, Ulises Gomez-Pinedo, Jordi A Matías-Guiu
Clinical or neuroimaging profiles in the assessment of genetic variants associated with neurodegenerative diseases. CNS neuroscience & therapeutics 25 (4) (2019)
Ulises Gómez-Pinedo, Jesús Adriel Cuevas, María Soledad Benito-Martín, Lidia Moreno-Jiménez, Noelia Esteban-Garcia, Laura Torre-Fuentes, Jordi A Matias-Guiu, Vanesa Pytel, Paloma Montero, Jorge Matias-Guiu
Vitamin D increases remyelination by promoting oligodendrocyte lineage differentiation. Brain and behavior 10 (1) (2019)
Jordi A Matias-Guiu, M N Cabrera-Martín, Jorge Matias-Guiu, J L Carreras
FDG-PET/CT or MRI for the Diagnosis of Primary Progressive Aphasia? AJNR. American journal of neuroradiology 38 (9) (2017)

Jorge Matias-Guiu.css-eqlu8i{font-size:small;padding-left:4px;} (Jorge Matías-Guiu, J Matías-Guiu)

Publication Activity (10 Years)

Top Topics

Top Venues

Jorge Matias-Guiu (Jorge Matías-Guiu, J Matías-Guiu)